Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Cripto-1 expression increases the expression of TNF-alpha in CD4+ T cells in tissues affected by chronic inflammatory disease. More
New methods of diagnosing and monitoring the progression or response to therapy of subjects with autoimmune hepatitis More
New surrogate biomarker to monitor the progression of HIV infection and other conditions and diseases associated with immune system activation More
Related Reports
Market Research Reports provided by reports.iptechex.com
May 2011 - 15 pages - $250
Jan 2010 - $75
Mar 2011 - 23 pages - $750
May 2006 - 74 pages - $2,500
May 2011 - 15 pages - $125
Feb 2011 - 11 pages - $995
Mar 2011 - 23 pages - $750
Dec 2010 - 37 pages - $500
Apr 2011 - 86 pages - $3,835
Sep 2010 - 25 pages - $125
Your selection
Browse By
- Therapeutic target
- Adoptive immunotherapy
- Amyloidosis
- Autoimmune disease (non-specific)
- Chronic fatigue syndrome
- Chronic granulomatous disease
- Chronic immunosuppression
- Gout
- Graft versus host disease
- HIV/AIDS
- Immune disorder (non-specific)
- Immune thrombocytopenic purpura
- Immunomodulation
- Immunostimulation
- Immunosuppression
- Lupus erythematosis
- Myalgic encephalomyelitis
- Myasthenia gravis
- Neoplastic disease
- Organ transplant rejection
- Rheumatoid arthritis
- Servere combined immunodeficency
- Sjogren's syndrome
- Systemic sclerosis
- Transplant rejection
- Xenotransplantation
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us